ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2,5,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2,6,Walking disability,Disability issues,Lifestyle issues,SocCi,N
3,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
3,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3,3,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
4,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
4,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
5,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
5,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
5,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
7,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
7,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
7,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
7,8,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
8,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
8,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
8,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
8,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,1,Bone marrow transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
9,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,3,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
11,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
11,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
11,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
11,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,1,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
13,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
14,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
14,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
15,2,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
16,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
17,1,Adenoidal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
18,1,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
19,1,Carpal tunnel decompression,Peripheral nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
20,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
20,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,6,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
20,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
21,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
21,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
22,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
22,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
23,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
23,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
24,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
24,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
25,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
25,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
25,3,Nasal discharge discolouration,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
26,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
26,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
27,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,2,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
27,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
28,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
31,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
32,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
32,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
32,3,Neutralising antibodies negative,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
32,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
33,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
34,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
35,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
36,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
37,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
38,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
39,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Infusion site discharge,Infusion site reactions,Administration site reactions,Genrl,N
40,2,Infusion site induration,Infusion site reactions,Administration site reactions,Genrl,N
41,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
41,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
41,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
41,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
42,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
42,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
43,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
44,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
45,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
45,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
47,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
47,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
